975 related articles for article (PubMed ID: 27184353)
1. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
2. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
3. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
[TBL] [Abstract][Full Text] [Related]
4. Platelet activation is less enhanced in the new balloon expandable Edwards Sapien 3 valve compared to its predecessor model (Edwards Sapien XT).
Fateh-Moghadam S; Voesch S; Htun P; Jorbenadze R; Geisler T; Gawaz M; Bocksch W
Thromb Haemost; 2016 Jan; 115(1):109-16. PubMed ID: 26311528
[TBL] [Abstract][Full Text] [Related]
5. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
6. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
[TBL] [Abstract][Full Text] [Related]
8. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
[TBL] [Abstract][Full Text] [Related]
9. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
10. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
[TBL] [Abstract][Full Text] [Related]
11. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
[TBL] [Abstract][Full Text] [Related]
12. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
[TBL] [Abstract][Full Text] [Related]
13. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
[TBL] [Abstract][Full Text] [Related]
14. Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis.
Conradi L; Schaefer A; Seiffert M; Schirmer J; Schaefer U; Schön G; Blankenberg S; Reichenspurner H; Treede H; Diemert P
Clin Res Cardiol; 2015 Sep; 104(9):735-42. PubMed ID: 25725778
[TBL] [Abstract][Full Text] [Related]
15. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
[TBL] [Abstract][Full Text] [Related]
16. Initial findings using the V8 hourglass-shaped valvuloplasty balloon for postdilatation in treating paravalvular leaks associated with transcatheter self-expanding aortic valve prosthesis.
Latib A; Pedersen W; Maisano F; Lesser J; Ruparelia N; Figini F; Colombo A; Poulose A; Kolbeck J; Mooney M; Schwartz R; Youssef A; Ungs D; Goldenberg I; Sorajja P
Catheter Cardiovasc Interv; 2016 Jun; 87(7):1306-13. PubMed ID: 26945697
[TBL] [Abstract][Full Text] [Related]
17. A Strategy of Underexpansion and Ad Hoc Post-Dilation of Balloon-Expandable Transcatheter Aortic Valves in Patients at Risk of Annular Injury: Favorable Mid-Term Outcomes.
Tan JS; Leipsic J; Perlman G; Stub D; Dvir D; Hansson NC; Norgaard BL; Blanke P; Cheung A; Ye J; Thompson CR; Moss RR; Lauck S; Wood D; Webb J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1727-32. PubMed ID: 26476612
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre.
Kaya D; Tanriverdi Z; Dursun H; Colluoglu T
Int J Cardiovasc Imaging; 2016 Sep; 32(9):1371-1378. PubMed ID: 27278270
[TBL] [Abstract][Full Text] [Related]
19. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT.
Yang TH; Webb JG; Blanke P; Dvir D; Hansson NC; Nørgaard BL; Thompson CR; Thomas M; Wendler O; Vahanian A; Himbert D; Kodali SK; Hahn RT; Thourani VH; Schymik G; Precious B; Berger A; Wood DA; Pibarot P; Rodés-Cabau J; Jaber WA; Leon MB; Walther T; Leipsic J
JACC Cardiovasc Interv; 2015 Mar; 8(3):462-471. PubMed ID: 25790764
[TBL] [Abstract][Full Text] [Related]
20. Outcome of paravalvular leak repair after transcatheter aortic valve replacement with a balloon-expandable prosthesis.
Dhoble A; Chakravarty T; Nakamura M; Abramowitz Y; Tank R; Mihara H; Mangat G; Jilaihawi H; Shiota T; Makkar R
Catheter Cardiovasc Interv; 2017 Feb; 89(3):462-468. PubMed ID: 27219874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
